
Aspira Women's Health AWH
Quarterly report 2025-Q3
added 11-14-2025
Aspira Women's Health EV/EBITDA Ratio 2011-2026 | AWH
Annual EV/EBITDA Ratio Aspira Women's Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.63 | -4.57 | -3.88 | -3.73 | -8.56 | -4.16 | -2.82 | -2.18 | -3.22 | -1.38 | -0.368 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.368 | -8.56 | -3.41 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Bioventus
BVS
|
26.4 | $ 9.24 | 2.72 % | $ 616 M | ||
|
Biodesix
BDSX
|
-4.25 | $ 15.58 | 6.06 % | $ 2.02 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 16.29 | -0.28 % | $ 493 M | ||
|
Guardant Health
GH
|
-28.8 | $ 83.67 | -1.52 % | $ 10.5 B | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 573.49 | -0.87 % | $ 46.1 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 74.3 | -1.89 % | $ 5.01 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 464.6 | 1.68 % | $ 13.4 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.68 | 0.54 % | $ 433 M | ||
|
National Research Corporation
NRC
|
21 | $ 17.21 | -1.71 % | $ 385 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.39 | - | $ 417 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Precipio
PRPO
|
-1.8 | $ 27.01 | 0.3 % | $ 35.1 M | ||
|
Personalis
PSNL
|
-7.07 | $ 7.78 | 2.23 % | $ 461 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
RadNet
RDNT
|
17.6 | $ 59.45 | -3.71 % | $ 4.47 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.7 | 1.21 % | $ 280 M | ||
|
Sotera Health Company
SHC
|
24.8 | $ 13.87 | -0.11 % | $ 3.94 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 31.01 | -2.25 % | $ 1.58 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 159.89 | 1.2 % | $ 7.92 B | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 167.87 | 0.55 % | $ 28.9 B | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.49 | -6.88 % | $ 98.3 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.19 | -18.49 % | $ 6.48 M | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 264.65 | 2.06 % | $ 26.1 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
Illumina
ILMN
|
70.5 | $ 125.94 | 1.74 % | $ 20 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 46.98 | 5.57 % | $ 2.81 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Celcuity
CELC
|
-2.38 | $ 102.11 | -4.35 % | $ 4.03 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 266.04 | 0.61 % | $ 22.1 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 3.49 | 0.29 % | $ 1.87 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 7.92 | -2.28 % | $ 1.01 B | ||
|
Natera
NTRA
|
-19.5 | $ 195.76 | -2.17 % | $ 19.3 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.83 | 1.54 % | $ 950 M | ||
|
OPKO Health
OPK
|
25.9 | $ 1.12 | -2.61 % | $ 777 M |